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On 17 June 2020, the World Health Organization released an update on their 
recommendations on the criteria for releasing COVID-19 patients from isolations (1). In the 
new update, the criteria required to release a symptomatic patients are 3 days without 
symptoms after 10 days from symptom onset (symptoms include fever and respiratory 
symptoms). The authors acknowledge the possibility that patients released from isolation 
with these criteria may still test positive for the COVID-19 virus (SARS-CoV-2) by RT-PCR, 
but they consider unlikely that they would be able to transmit the virus to another person. 
Since 23 March 2020, we have monitored and are still monitoring patients discharged from 
the Luigi Sacco Hospital of Milan during their home isolation through the Operations 
Center for Discharged Patients (COD19). COD19 is an active surveillance service for home-
care patients operated by resident doctors via phone calls. At discharge, patients are 
provided with hydroxychloroquine and lopinavir/ritonavir therapy, and  a thermometer 
and a pulse oximeter for parameter monitoring. Parameters are collected once or twice a 
day, and include body temperature, oxygen saturation at rest and after 6-minute walk test, 
respiratory rate, and COVID-19 related symptoms. The service also serves as the reporting 
J
urn
al 
Pr
-pr
f
Letter to the Editor 
service for patients ready to be tested for release. The criteria currently enforced require 
all confirmed COVID-19 diagnosis 2 negative swab tests after 14 days without symptoms. 
To put in context the updated WHO recommendations, we share the results of swab test 
performed after an accurate assessment of 14 days without symptoms on patients with a 
confirmed COVID-19 diagnosis. Of 314 confirmed diagnosis, 226 (72·0%) tested negative 
after 14 days without symptoms, 54 (17·2%) tested weak positive, and 34 (10·8%) tested 
positive for the COVID-19 virus. Figure 1 shows after how many days from symptom onset 
those swab were performed. Positive tests were obtained with a minimum of 14 days from 
symptom onset to a maximum of 73 days, with a median of 33 days. While most patients 
tested negative or weak positive, the markedly positive results found in almost 11% of our 
sample may cause some concern, also considering that stricter criteria (14 days vs. 3 days) 
were applied in this case. 
These data can guide countries who may choose to continue to use testing as part of the 
release criteria of patients with confirmed COVID-19 diagnosis. 
 
Figure 1: Frequency of swab results (binwidth = 5 days) 
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